Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Drucker

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Diabetes|January 24, 2015
Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting LectureDaniel J Drucker
Cell Metabolism|February 2, 2021
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginningDaniel J Drucker
Diabetes Care|September 30, 2003
Enhancing incretin action for the treatment of type 2 diabetesDaniel J Drucker
The Diabetes Educator|March 24, 2006
The evidence for achieving glycemic control with incretin mimeticsDaniel J Drucker
Nature Reviews. Drug Discovery|December 19, 2019
Advances in oral peptide therapeuticsDaniel J Drucker
The Journal of Clinical Investigation|January 4, 2007
The role of gut hormones in glucose homeostasisDaniel J Drucker
The Journal of Clinical Endocrinology and Metabolism|December 10, 2015
Evolving Concepts and Translational Relevance of Enteroendocrine Cell BiologyDaniel J Drucker
ACS Pharmacology & Translational Science|March 29, 2020
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel SyndromeDaniel J Drucker
Nature Reviews. Endocrinology|November 21, 2024
Expanding applications of therapies based on GLP1Daniel J Drucker
Endocrinology|December 3, 2003
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosisDaniel J Drucker
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Diabetes|January 24, 2015
Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting LectureDaniel J Drucker
Cell Metabolism|February 2, 2021
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginningDaniel J Drucker
Diabetes Care|September 30, 2003
Enhancing incretin action for the treatment of type 2 diabetesDaniel J Drucker
The Diabetes Educator|March 24, 2006
The evidence for achieving glycemic control with incretin mimeticsDaniel J Drucker
Nature Reviews. Drug Discovery|December 19, 2019
Advances in oral peptide therapeuticsDaniel J Drucker
The Journal of Clinical Investigation|January 4, 2007
The role of gut hormones in glucose homeostasisDaniel J Drucker
The Journal of Clinical Endocrinology and Metabolism|December 10, 2015
Evolving Concepts and Translational Relevance of Enteroendocrine Cell BiologyDaniel J Drucker
ACS Pharmacology & Translational Science|March 29, 2020
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel SyndromeDaniel J Drucker
Nature Reviews. Endocrinology|November 21, 2024
Expanding applications of therapies based on GLP1Daniel J Drucker
Endocrinology|December 3, 2003
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosisDaniel J Drucker
Pageof 32